Press Releases
 
Research delivers insight into the CAR-T Cell Therapy Market worthUS$ XXBn USD by 2026

The CAR-T cell therapy market is driven by factors such as rising prevalence of cancer, growing research in the immune-oncology, and massive funding from government health institution and pharma giants in CAR-T cell therapy development

United States, 13 August 2018 -- the global CAR-T cell therapy market was valued at US$ 72.0 Mn in 2017 expanding at a CAGR of 51.1% from 2018 to 2026.

The latest market report published by Credence Research, Inc. “CAR-T Cell Therapy Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global CAR-T cell therapy market was valued at US$ 72.0 Mn in 2017 expanding at a CAGR of 51.1% from 2018 to 2026.
Browse the full report CAR-T Cell Therapy Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/car-t-cell-therapy-market
Market Insights
The CAR-T cell therapy market is driven by factors such as rising prevalence of cancer, growing research in the immune-oncology, and massive funding from government health institution and pharma giants in CAR-T cell therapy development. The diagnosis of acute ALL is very ambiguous as the symptoms overlap with Non-Hodgkin lymphoma. World Health Organization guidelines have postulated that acute lymphocytic leukemia can be prevented up to a certain extent by prohibiting the exposure to radiation, chemical, viral infection, cigarette smoking and prolonged exposure to gasoline and electromagnetic fields. The traditional approach adopted for the treatment of leukemia was blood transfusion to increase the count of healthy blood cells, antibiotics used to curb the spread of infection and chemotherapy to kill the leukemia cells present in the bone marrow. However, advances in the cell therapy and gene therapy has have rendered the development of oncology treatment by body’s own immune system. The FDA approved CAR T cell therapy are Axicabtagene ciloleucel (Yescarta) and Tisagenleucel (Kymriah),). Currently CD19 antigens have been approved by USFDA for the treatment of relapsed b-cell acute lymphocytic leukemia. Whereas, there are more than 2,000 candidates in the clinical trials for different cancer indications.
CD19 antigens as CAR T cell therapy for the treatment of B cell acute lymphocytic leukemia and increasing number of children suffering with acute lymphocytic leukemia is responsible for the dominance of ALL. Geographically, North America dominated the CAR-T cell therapy market due to approval of two CAR-T cell therapy candidates in the region. Moreover, rising prevalence of relapsed acute lymphocytic leukemia and technological advancement in the screening of cancer drives the CAR-T cells therapy market. Moreover, the domicile of pharmaceutical companies pioneering in CAR-T cell therapy further increases the dominance of United States. Increasing geriatric population suffering with leukemia and government initiatives to fight cancer will result in the growth of CAR-T cell therapy in Europe and Asia Pacific. However, penetration of CAR-T cell therapy within low and middle income economies are primarily hampered owing to the unavailability of suitable healthcare infrastructure and the lack of disposable income for such premium priced therapeutic options. The major pharmaceutical players actively engaged in the CAR-T cell therapy market are Gilead Sciences, Inc., Bellicum Pharmaceuticals, Inc., Immune Therapeutics, Celgene Corporation, Cellectis, Kite Pharma, Eureka Therapeutics, Juno Therapeutics, Sorrento Therapeutics and Novartis AG among others.
Key Market Movements:
• Rising prevalence of patients suffering with relapsed b cell acute lymphocytic leukemia
• Proactive role adopted by regulatory agencies for the expedited approval of CAR T cell therapy
• Promising pipeline for CAR-T cell therapy focusing on CD22, CD30 antigens for the treatment of non-Hodgkin’s lymphoma and acute myeloid leukemia respectively
• Higher adoption of Immunotherapy for cancer treatment in North America and Europe contribute towards the growth of the market
• Partnerships, collaboration and capital funding between pharmaceutical giants and budding biotechnology to increase research and development of immunotherapy for cancer treatment.
Request Sample: https://www.credenceresearch.com/sample-request/58970
Browse the full report CAR-T Cell Therapy Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/car-t-cell-therapy-market
Related Reports:
https://www.credenceresearch.com/report/baggage-scanners-market
https://www.credenceresearch.com/report/emi-shielding-materials-market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free(US/CANADA): +1-800-361-8290
Web: https://www.credenceresearch.com

# # #


Document Attached Image Attached Download file at: 95103
(Right click and save file to download.)

Submitted by Acute Market Reports, Acute Market Research on Monday, 13 August 2018 at 2:15 PM
Category: Business
 
Related News

Young refugees in the Jordanian-Emirati refugee camp set to receive University Education
Tuesday, 26 Mar 2019

Astrindo Nusantara Infrastructure ("BIPI") Refinances Credit Suisse Loan
Tuesday, 26 Mar 2019

Andre Porter Book to Film Tour
Tuesday, 26 Mar 2019

Safezone.Tips Stand The Best Place Online To Get Free SafeZone Pass To Start Exploring
Monday, 25 Mar 2019

New Silkroutes Group sells its energy unit for US$10 million
Monday, 25 Mar 2019

Related Events

Gulf Safety Forum 2019
Monday, 25 Mar 2019

Catering Equipment and Services Forum
Monday, 25 Mar 2019

CRU Phosphates 2019
Monday, 25 Mar 2019

INFOAG INTERNATIONAL
Monday, 25 Mar 2019

Argus Middle East Fertilizer
Monday, 25 Mar 2019

Latest News

Khaled Al Badie to Take Steps to Boost Business Productivity of ABG
Tuesday, 26 Mar 2019

Young refugees in the Jordanian-Emirati refugee camp set to receive University Education
Tuesday, 26 Mar 2019

Astrindo Nusantara Infrastructure ("BIPI") Refinances Credit Suisse Loan
Tuesday, 26 Mar 2019

Time to Join Pandora’s Box for April Fools' Day with 700M Free rs3 gold Apr.1
Tuesday, 26 Mar 2019

200M Free rs 07 gold in RSorder Pandora’s Box for April Fools' Day Apr.1!Ready?
Tuesday, 26 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 26 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Diagnostic Imaging Update on Kauai
  • Catering Equipment and Services Forum
  • CRU Phosphates 2019
  • Hospitality Tech and Innovation Fourm
  • Gulf Safety Forum 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.